Tag: "described" at medical news

Cancer Protection Compound Abundant In Broccoli Sprouts

...f sulforaphane's chemoprotective properties. Work described in thestudy is thesubject of issued and pending patents. A systematic search for dietary sources of compounds that increaseresistance tocancer-causing agents led the Hopkins group to focus on naturally occurringcompounds inedible plants that m...

NIH Honors Emory Researcher With Merit Award For Work On Renin-Angiotensin System

...d." In a 1994 article in Nature, Bernstein described the unique messagingpathway used by the AT1 receptor to send messages from the cell surface to thecell nucleus. In response to angiotensin II, the AT1 receptor activates anintracellular messenger called the Jak2 kinase, which in turn initiates acas...

Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors

...V-infected patients. The nationwide study described in the article found that the numberHIV-related deaths decreased from almost 30 per 100 person-years in 1994 toabout 9 per 100 person-years by mid-1997. At around the same time, prescriptionrates of combination antiretroviral therapy increased from 2...

BioNumerik Reports Preclinical Antitumor Data On Two Novel Supercomputer Engineered Anticancer Agents At 89th Annual AACR Conference

...red to water solublecamptothecins. Camptothecins, described as Topoisomerase I inhibitors, represent some of themost active anticancer drugs in existence. Due to formulation problems,however, the great majority of camptothecins in development or on the markethave been made water soluble to allow easier drug ...

Anti-Clotting Drug May Cause Potentially Fatal Platelet Disorder

...re generally unaware of this side effect, which is described as"having a rare association" in the package insert produced by the pharmaceuticalmanufacturer, Hoffmann-LaRoche of Basel, Switzerland. Ticlopidine's toxicity has raised concern since its approval by the Foodand Drug Administration. Early cli...

Most People Cant Identify Stroke Symptoms

... sudden severe headache with no known cause (often described as the worst headache in a person's life). The investigators found that only 57 percent of the study participants correctly listed at least one of these five symptoms or warning signs, 28 percent correctly listed two or more, and 8 percent correctly...

ONYX Pharmaceuticals Reports Phase II Clinical Trial Results At ASCO Meeting

...ecompany's expectations.In addition to the matters described in this pressrelease, the timeline for clinical activity, results of pending or futureclinical trials, including the trials of ONYX-015, and changes in the status ofthe company's collaborative relationships, as well as the riskfactors listed from tim...

New Elementary School Program Lowers Cardiovascular Risks In Children

...(NINR), NIH. The findings from the CHIC study are described in the August 3 issue of PEDIATRICS. This is the first study to test the program on children with at least two CVD risk factors and to compare the effectiveness of a classroom-wide program with a program providing more individualized interventions. T...

'DES Daughters' Had Increased Rates of Cancer; An Animal Study Shows 'DES Granddaughters' May Too

...s in male mouse siblings in which like thefemales described in this study, reproduction is not affected but rare cancersare observed. A report on the effects in males is being completed, Newboldsaid. Newbold and her colleagues said that although additional study of risksfrom environmental agents ar...

Electronic Nose Inspects Cheese, Hints At Human Sense Of Smell

... cheeses. It noted that the cheese which panelists described as especially sharp smelled... different from the onethey described as especially bland. The device also agreedwith the human panelists that the ...

UNC-CH Studies Show Medicine Can Reverse Osteoporosis From Transplants, Cystic Fibrosis

... in cystic fibrosis patients. The studies, described at the 12th Annual North American Cystic FibrosisConference in Montreal that ended Sunday (Oct. 18), found that patients treatedwith Pamidronate experienced about a 10 percent reversal of bone loss caused byimmuno-suppressant drugs. Drs. Robe...

Duke Physicians: Clinicians Have Ethical Obligation To Consider Alternative Medicine

...ericanMedical Association. In the article, described as a "policy perspective," Drs. JeremySugarman and Larry Burk tackle the question of the traditional clinician's rolein a patient's use of alternative medical treatment. The issue focuses onalternative medicine. "We have taken a hard look ...

Maxim Phase II Clinical Trial Highlights Substantial Increase In Leukemia-FreeSurvival For Acute Myelogenous Leukemia Patients

...r immunotherapies. Complementing the AML results described above, Phase II clinical studies ofMaxamine Therapy in advanced malignant melanoma have shown a more than doublingin survival outcomes and the maintenance of patient quality of life duringtreatment. Earlier-stage clinical studies have also suggested...

Nerve Agent Sensor A Million Times More Sensitive

...the arsenals of some countries. The sensor is described in the January 15 print edition of the peerreviewed journal Analytical Chemistry, published by the American ChemicalSociety, the world's largest scientific society. The web edition of the articlewaspublished Dec. 10. The sensor, which combines ...

Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV

...broad potential to make adoptive immunotherapy, as described inthis paper, a clinical reality. FHCRC was issue.... The REM technology overcomes this hurdleand, as described in the publication, rapidly expands antigen-specific cells tonumbers greater than one billion, which...

New Surgery At Cedars-Sinai Provides Hope For Epilepsy Patient Who Has Had A Lifetime Of Seizures

... years. "I typically would just stare into space," described Mary Kate, adding that shesometimes blacked out or would remain aware but unable to speak. "I've beenfortunate -- I didn't fall down on the floor or tear my clothes off oranything." But there have been some close calls and frightening moments. Whent...

Immunex's TRAIL Molecule Shows Potential As Anti-Tumor Agent

...mors, by adirect and specific mechanism. The work described in the journal was conductedin mice by scientists ...provals, product commercialization and other risks described fromtime to time in the SEC reports filed by Immunex, including the most recentlyfiled Form 10K and ...

Far Few Drugs Are Tested On Children

... atthe Children's Hospital in Birmingham, Alabama, described 30 years ago as"pharmaceutical orphans"....

Promising Bone Cancer Therapy Advances To Next Level

...nnual scientificmeeting in Hawaii. He also described the current nationwide clinical trial, designed totest the compound's potency in giving pain relief to patients whose cancer hasspread to the bone. Diatide Inc., a New Hampshire biotechnology company that has licensedthe technology from BNL...

UW-Madison Center One Of Two Sites Nationwide Selected For Clinical Trial Of Cancer Drug

...e attentionafter a May 1998 New York Times article described early results in mice in thelaboratory of Dr. Judah Folkman of Harvard Medical School. In May 1998, the NCIcalled animal studies on the compound "encouraging" and later announced it wouldentertain applications from research organizations to conduct t...

1 2 3 4 5 6 7 8 9 10

(Date:11/22/2014)... SAN JOSE, Calif. (PRWEB) November 22, 2014 ... related security applications was announced today which safely ... body using high frequency radio waves. Developed by ... nude images and hosts broad applications in other ... in addition to security. , Using high frequency ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 “Greenfield Naturals” ... Tech Report , which features the latest and ... technology expert and reporter for NewsWatch, conducted the product ... improve the flavor of your water. , From pollution ... It’s important that everything is done to remove these ...
(Date:11/22/2014)... OH (PRWEB) November 22, 2014 A Xarelto ... York woman who is seeking $10 million in damages from ... thinner . According to the lawsuit, the woman began using ... The woman alleges in her lawsuit she suffered life-threatening bleeding ... permanent personal injuries, pain, suffering and emotional distress. The lawsuit ...
(Date:11/22/2014)... 21, 2014 (HealthDay News) -- Many young people consider ... a new study finds fumes from the water pipes ... to an increased risk for leukemia in prior research, ... the journal Cancer Epidemiology, Biomarkers & Prevention . ... smoking is not a safe alternative to smoking other ...
(Date:11/22/2014)... By Steven Reinberg ... -- Stroke outcomes are better when patients are treated in ... and clot-busting drugs, German researchers report. The sooner patients ... the better the outcome after a stroke, the researchers noted. ... within the first hour after stroke symptoms start, the researchers ...
Breaking Medicine News(10 mins):Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3
Other Tags
birdsourcecashewphoeniximposterdouglaskolodnerlandonsixthlimonoidssupchemoembolizationcholestinsmilefrownbillionsexpose